These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35032444)

  • 41. Face-to-face: isotretinoin use and pregnancy outcome.
    Tırmıkçıoğlu Z; Tatlıparmak A
    Int J Dermatol; 2024 Feb; 63(2):232-238. PubMed ID: 38095245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. First trimester mechanisms of gestational sac placental and foetal teratogenicity: a framework for birth cohort studies.
    Adibi JJ; Layden AJ; Birru RL; Miragaia A; Xun X; Smith MC; Yin Q; Millenson ME; O'Connor TG; Barrett ES; Snyder NW; Peddada S; Mitchell RT
    Hum Reprod Update; 2021 Jun; 27(4):747-770. PubMed ID: 33675653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Teratology and epidemiology in the study of environmental teratogens].
    Cayré R; Sánchez-Gómez C; Moreno-Rodríguez RA; de la Cruz MV
    Bol Med Hosp Infant Mex; 1992 Jul; 49(7):397-403. PubMed ID: 1418645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cross-sectional evaluation of prescription of valproate and other antiepileptic drugs to pregnant women.
    Aykan DA; Ergün Y
    Acta Neurol Belg; 2021 Apr; 121(2):503-508. PubMed ID: 31659713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Isotretinoin (Roaccutane) in women of childbearing age: failure of following prescription guidelines].
    Autret E; Radal M; Jonville-Béra AP; Goehrs JM
    Ann Dermatol Venereol; 1997; 124(8):518-22. PubMed ID: 9740842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015.
    Engeland A; Bjørge T; Klungsøyr K; Hjellvik V; Skurtveit S; Furu K
    Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):995-1004. PubMed ID: 29920833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Teratogenic effects of antiepileptic medications.
    Tomson T; Battino D
    Neurol Clin; 2009 Nov; 27(4):993-1002. PubMed ID: 19853219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Foetal safety of old and new antiepileptic drugs.
    Verrotti A; Mencaroni E; Castagnino M; Zaccara G
    Expert Opin Drug Saf; 2015 Oct; 14(10):1563-71. PubMed ID: 26329145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prescription medication use during pregnancy in the United States from 2011 to 2020: trends and safety evidence.
    Mansour O; Russo RG; Straub L; Bateman BT; Gray KJ; Huybrechts KF; Hernández-Díaz S
    Am J Obstet Gynecol; 2024 Aug; 231(2):250.e1-250.e16. PubMed ID: 38128861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
    Tomson T; Perucca E; Battino D
    Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crack cocaine smoke on pregnant rats: Maternal evaluation and teratogenic effect.
    Souza-Silva EM; Alves RB; Simon KA; Hueza IM
    Hum Exp Toxicol; 2020 Apr; 39(4):411-422. PubMed ID: 31789068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Teratogenic mechanisms of medical drugs.
    van Gelder MM; van Rooij IA; Miller RK; Zielhuis GA; de Jong-van den Berg LT; Roeleveld N
    Hum Reprod Update; 2010; 16(4):378-94. PubMed ID: 20061329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000-2020.
    Mahesri M; Sarpatwari A; Huybrechts KF; Lii J; Lee SB; Toyserkani GA; LaCivita C; Zhou EH; Dal Pan GJ; Kesselheim AS; Bykov K
    Drug Saf; 2024 Sep; 47(9):909-919. PubMed ID: 38755509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic procedure for the classification of proven and potential teratogens for use in research.
    Eltonsy S; Martin B; Ferreira E; Blais L
    Birth Defects Res A Clin Mol Teratol; 2016 Apr; 106(4):285-97. PubMed ID: 26969841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Teratology: general considerations and principles.
    Finnell RH
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 2):S337-42. PubMed ID: 9949334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Developmental effects of antiepileptic drugs and the need for improved regulations.
    Meador KJ; Loring DW
    Neurology; 2016 Jan; 86(3):297-306. PubMed ID: 26519545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiepileptic drug combinations not involving valproate and the risk of fetal malformations.
    Vajda FJ; O'Brien TJ; Lander CM; Graham J; Eadie MJ
    Epilepsia; 2016 Jul; 57(7):1048-52. PubMed ID: 27265509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Teratogenic potential of the newer antiepileptic drugs: what is known and how should this influence prescribing?
    Palmieri C; Canger R
    CNS Drugs; 2002; 16(11):755-64. PubMed ID: 12383031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pregnancy outcomes in women reporting ingestion of levosulpiride in early pregnancy.
    Shin YJ; Choi JS; Ahn HK; Ryu HM; Kim MY; Han JY
    J Obstet Gynaecol; 2017 Nov; 37(8):992-995. PubMed ID: 28631490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.
    Taguchi N; Rubin ET; Hosokawa A; Choi J; Ying AY; Moretti ME; Koren G; Ito S
    Reprod Toxicol; 2008 Oct; 26(2):175-7. PubMed ID: 18640262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.